赛伦生物
(688163)
| 流通市值：6.50亿 | | | 总市值：15.84亿 |
| 流通股本：4437.20万 | | | 总股本：1.08亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 124,093,875.96 | 150,921,948.01 | 121,998,400.36 | 103,882,705.44 |
| 应收票据及应收账款 | 38,499,090.2 | 22,634,950.22 | 42,946,027.36 | 52,081,212.77 |
| 应收账款 | 38,499,090.2 | 22,634,950.22 | 42,946,027.36 | 52,081,212.77 |
| 预付款项 | 1,109,076.07 | 1,489,329.52 | 3,280,557.01 | 1,086,850 |
| 其他应收款合计 | 1,110,999.94 | 712,416.7 | 1,067,559 | 1,001,848 |
| 存货 | 47,437,803.13 | 44,748,509.91 | 44,039,655.18 | 49,200,185.89 |
| 其他流动资产 | 5,844,519.13 | 5,832,375.59 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 940,355,041.14 | 948,930,376.53 | 956,456,829.05 | 936,094,130.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 15,603,515.97 | 16,593,941.81 | 11,985,687.87 | 15,412,421.24 |
| 固定资产 | 57,192,757.72 | 58,351,109.28 | 56,338,053.92 | 54,927,358.87 |
| 在建工程 | 59,655,542.87 | 54,604,190.26 | 53,131,415.1 | 47,668,319.98 |
| 生产性生物资产 | 4,579,325.35 | 3,460,677.25 | 5,049,965.26 | 4,815,274.04 |
| 使用权资产 | 11,179,336.92 | 11,407,486.65 | 11,635,636.38 | 11,863,786.11 |
| 无形资产 | 23,600,263.52 | 23,789,652.77 | 23,789,956.03 | 23,974,662.58 |
| 长期待摊费用 | 814,611.33 | 874,598.07 | 934,584.81 | 994,571.55 |
| 递延所得税资产 | 9,962,731.57 | 9,909,713.01 | 9,794,277.71 | 10,062,897 |
| 其他非流动资产 | 22,500 | 550,800 | 22,500 | 657,969.68 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 182,610,585.25 | 179,542,169.1 | 172,682,077.08 | 170,377,261.05 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,122,965,626.39 | 1,128,472,545.63 | 1,129,138,906.13 | 1,106,471,391.92 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 3,398,481.68 | 3,635,753.93 | 3,785,936.27 | 2,809,153.46 |
| 应付账款 | 3,398,481.68 | 3,635,753.93 | 3,785,936.27 | 2,809,153.46 |
| 合同负债 | 2,642,029.4 | 2,926,660.83 | 2,999,791.9 | 2,592,107.12 |
| 应付职工薪酬 | 1,935,091.96 | 7,686,022.26 | 2,581,731.82 | 4,692,432.64 |
| 应交税费 | 1,475,097.24 | 460,639.9 | 2,438,985.25 | 2,301,825.04 |
| 其他应付款合计 | 7,541,349.2 | 9,431,873.61 | 6,946,685.91 | 7,050,866.14 |
| 应付股利 | 16,500 | 16,500 | 16,500 | 16,500 |
| 一年内到期的非流动负债 | 758,429.43 | 758,429.43 | 1,372,985 | 1,372,985 |
| 其他流动负债 | 97,794.22 | 86,392.72 | 76,521.54 | 77,763.21 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 17,848,273.13 | 24,985,772.68 | 20,202,637.69 | 20,897,132.61 |
| 非流动负债: | | | | |
| 租赁负债 | 12,356,008.9 | 12,200,215.63 | 12,112,147.35 | 12,638,634.64 |
| 递延所得税负债 | 5,445,951.85 | 5,445,951.85 | 5,560,026.72 | 5,560,026.72 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 17,801,960.75 | 17,646,167.48 | 17,672,174.07 | 18,198,661.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 35,650,233.88 | 42,631,940.16 | 37,874,811.76 | 39,095,793.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 871,487,814.86 | 871,487,814.86 |
| 盈余公积 | 45,817,944.54 | 45,817,944.54 | 41,608,687.43 | 41,608,687.43 |
| 未分配利润 | 55,189,633.11 | 53,714,846.07 | 69,947,592.08 | 46,059,095.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,087,315,392.51 | 1,085,840,605.47 | 1,091,264,094.37 | 1,067,375,597.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,087,315,392.51 | 1,085,840,605.47 | 1,091,264,094.37 | 1,067,375,597.95 |
| 负债和股东权益合计 | 1,122,965,626.39 | 1,128,472,545.63 | 1,129,138,906.13 | 1,106,471,391.92 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |